PERIOPERATIVE TREATMENT WITH COI-B (CAPECITABINE, OXALIPLATIN, IRINOTECAN AND BEVACIZUMAB) OF HIGH RISK OR BORDERLINE RESECTABLE COLORECTAL CANCER LIVER METASTASES
Clinical trial NCT02086656 · COMPLETED
Trial details
- NCT number
- NCT02086656
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2017-03-30
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.